Ra Capital Management, Llc Buys Novavax Inc, Satsuma Pharmaceuticals Inc, Macrogenics Inc, Sells Ra Pharmaceuticals Inc, Exelixis Inc, Gilead Sciences Inc

• New Purchases: NVAX, STSA, MGNX, PHAT, BDTX, LEGN, IGMS, KROS, GERN, ETNB, AKUS, ARQT, AVDL, IMRA, OCUL, LRMR, STRO, SNDX, CLDX, RPTX, LYRA, PASG, ARYBU, GRTX, OVID,
• Added Positions: TGTX, CCXI, ADVM, AXSM, RTRX, CRNX, ADAP,
• Reduced Positions: ZGNX, VSTM, RLMD, PRVL, RYTM, SELB, TRIL, ARDX, EPIX, XFOR,
• Sold Out: RARX, EXEL, GILD, CGEN, IMGN, NVCR, QURE, PTLA, VCEL,

For the details of RA CAPITAL MANAGEMENT, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/ra+capital+management%2C+llc/current-portfolio/portfolio

1. Ascendis Pharma A/S (ASND) - 4,914,955 shares, 16.01% of the total portfolio.
2. Novavax Inc (NVAX) - 4,758,833 shares, 8.74% of the total portfolio. New Position
3. ChemoCentryx Inc (CCXI) - 4,826,910 shares, 6.12% of the total portfolio. Shares added by 15.56%
4. TG Therapeutics Inc (TGTX) - 12,788,457 shares, 5.49% of the total portfolio. Shares added by 23.11%
5. Axsome Therapeutics Inc (AXSM) - 2,035,132 shares, 3.69% of the total portfolio. Shares added by 6.88%

Ra Capital Management, Llc initiated holding in Novavax Inc. The purchase prices were between $13.58 and $83.61, with an estimated average price of $37.67. The stock is now traded at around $95.45. The impact to a portfolio due to this purchase was 8.74%. The holding were 4,758,833 shares as of .

Ra Capital Management, Llc initiated holding in Satsuma Pharmaceuticals Inc. The purchase prices were between $16.01 and $34.69, with an estimated average price of $23.09. The stock is now traded at around $4.83. The impact to a portfolio due to this purchase was 2.97%. The holding were 4,681,858 shares as of .

Ra Capital Management, Llc initiated holding in Macrogenics Inc. The purchase prices were between $5.2 and $29.12, with an estimated average price of $17.14. The stock is now traded at around $26.87. The impact to a portfolio due to this purchase was 2.82%. The holding were 4,584,652 shares as of .

Ra Capital Management, Llc initiated holding in Phathom Pharmaceuticals Inc. The purchase prices were between $25.06 and $54.6, with an estimated average price of $38.17. The stock is now traded at around $34.65. The impact to a portfolio due to this purchase was 2.77%. The holding were 3,825,008 shares as of .

Ra Capital Management, Llc initiated holding in Black Diamond Therapeutics Inc. The purchase prices were between $22.3 and $44.8, with an estimated average price of $36.52. The stock is now traded at around $29.50. The impact to a portfolio due to this purchase was 2.41%. The holding were 2,589,904 shares as of .

Ra Capital Management, Llc initiated holding in Legend Biotech Corp. The purchase prices were between $36.1 and $42.56, with an estimated average price of $39.07. The stock is now traded at around $31.05. The impact to a portfolio due to this purchase was 2.33%. The holding were 2,481,942 shares as of .

Ra Capital Management, Llc added to a holding in TG Therapeutics Inc by 23.11%. The purchase prices were between $8.9 and $21.84, with an estimated average price of $16.01. The stock is now traded at around $24.91. The impact to a portfolio due to this purchase was 1.03%. The holding were 12,788,457 shares as of .

Ra Capital Management, Llc sold out a holding in Ra Pharmaceuticals Inc. The sale prices were between $48 and $48.01, with an estimated average price of $48.

Ra Capital Management, Llc sold out a holding in Exelixis Inc. The sale prices were between $16.46 and $27.42, with an estimated average price of $23.03.

Ra Capital Management, Llc sold out a holding in Gilead Sciences Inc. The sale prices were between $72.34 and $84, with an estimated average price of $76.51.

Ra Capital Management, Llc sold out a holding in Compugen Ltd. The sale prices were between $6.97 and $17.12, with an estimated average price of $13.35.

Ra Capital Management, Llc sold out a holding in NovoCure Ltd. The sale prices were between $57.2 and $74.41, with an estimated average price of $65.86.

Ra Capital Management, Llc sold out a holding in Immunogen Inc. The sale prices were between $3.32 and $5.34, with an estimated average price of $4.24.

Ra Capital Management, Llc reduced to a holding in Zogenix Inc by 30.29%. The sale prices were between $22.26 and $32.04, with an estimated average price of $27.52. The stock is now traded at around $24.18. The impact to a portfolio due to this sale was -1.47%. Ra Capital Management, Llc still held 3,677,424 shares as of .